LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues
The Canadian-based biopharma company MindBio Therapeutics Corp. CSE: MBIO obtained regulatory approval for a series of clinical trials in women's health using its proprietary LSD drug, MB22001. The company said it is the only one in the world with regulatory approvals of the take-home use of this type of scheduled drug in clinical trials. <
